Real-time enrollment status for this gastric cancer clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:01 PM UTC
| NCT Number | NCT06901531 |
| Recruiting Status | Recruiting |
| Condition | Gastric Cancer |
| Phase | PHASE3 |
| Target Enrollment | 500 participants |
| Active Locations | 37 sites in the US |
| Sponsor | Astellas Pharma Global Development, Inc. |
| Last Updated on CT.gov | September 24, 2026 (3 weeks ago) |
As of October 15, 2026: Clinical trial NCT06901531 is currently recruiting participants. This phase3 study for gastric cancer is actively seeking new participants at 37 locations across the United States. The study is sponsored by Astellas Pharma Global Development, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06901531 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 37 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06901531 was last updated 3 weeks ago (September 24, 2026). HelloStudys verifies this status automatically.